{
    "2015-05-30": [
        "Bristolâ€™s Shares Take Hit From Cancer-Drug Results - WSJ $BMY $MRK",
        "$TSRO $MRK: TESARO and Merck to Collaborate on a Combination Study",
        "#ASCO15 $MRK Keytruda very impressive data in MMR-deficient CRC, smart with an established biomarker",
        "Pembrolizumab in SCLC in KEYNOTE-028: ORR 35%. 7 PRs. 1 pt died from gr 5 colitis under investigation. #ASCO15 $MRK",
        "#ASCO15 $MRK Keytruda data in MMR-deficient CRC in NEJM Amazing true predictive biomarker!",
        "#ASCO15 @JohnCFierce Most exciting data so far $BMY Opdivo HCC $MRK Keytruda MMR-deficient"
    ]
}